Navigation Links
Vascular Study Group of New England Selects Clinical Data Pathways, Powered by M2S, as Quality Improvement Registry Provider
Date:10/20/2009

M2S, Inc. and the Vascular Study Group of New England (VSGNE) have partnered to advance the VSGNE quality improvement registry. Clinical Data Pathways, powered by M2S, is a secure, web-based clinical data management solution that offers physicians, hospitals, medical centers and clinical researchers the power to assess outcomes, enhance clinical quality and improve practice standards while providing the customer with complete control of their data.

West Lebanon, NH (PRWEB) October 20, 2009 -- M2S, Inc. and the Vascular Study Group of New England (VSGNE) have partnered to advance the VSGNE quality improvement registry. Clinical Data Pathways, powered by M2S, is a secure, web-based clinical data management solution that offers physicians, hospitals, medical centers and clinical researchers the power to assess outcomes, enhance clinical quality and improve practice standards while providing the customer with complete control of their data.

The VSGNE quality improvement registry, formed in 2002, has prospectively collected data on more than 12,000 patients undergoing carotid endarterectomy, carotid stenting, lower extremity arterial bypass and open and endovascular repair of abdominal aortic aneurysms. There are currently twelve hospital members of the VSGNE from Massachusetts, Maine, New Hampshire and Vermont. By studying their outcomes, the group has been able to identify best processes of care and better patient selection algorithms to improve patient outcomes.

It is the vision of both the VSGNE and M2S that the vascular quality improvement registry model will be replicated in other regions of the United States, facilitating widespread benchmarking and quality initiatives to improve patient outcomes. The collection and exchange of anonymous aggregate data across multiple participants in the registry fosters continuous improvement in the quality, safety, effectiveness and cost of caring for patients.

"M2S is excited to be part of the VSGNE's mission to improve quality and enhance clinical outcomes within the region and across the country. As a provider of leading medical imaging tools for vascular surgeons, our company embraces technological advances and are certain that our data management solution will meet the growing needs of healthcare organizations," M2S CEO Wes Chapman commented.

"We selected M2S as our vendor because of its experience with vascular image management registries, its status as a six sigma company with established protocols for data integrity and its powerful database platform using Oracle Clinical," Jack Cronenwett, M.D. from Dartmouth-Hitchcock Medical Center and Principal Investigator of the VSGNE, stated.


About M2S, Inc.
M2S offers medical data and image management services across the healthcare continuum based on best-in-class technology and continuous quality improvement processes, including clinical data management solutions, clinical trials and advanced radiographic image analysis. With over 10 years of experience, M2S has created Clinical Data Pathways to give health care providers greater ownership and control of patient data, provide real-time access to risk-adjusted benchmarked reports and facilitate local, regional and national data collaboration. All M2S services focus on increasing operational efficiency, reducing total cost and maintaining or enhancing clinical quality. For more information, visit www.m2s.com.

###

Read the full story at http://www.prweb.com/releases/medical/imaging/prweb3074594.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Study questions need for routine intervention in patients with renovascular disease
2. Good Samaritan Hospital-Dayton Rated #1 in Ohio for Vascular Surgery; #1 in Dayton for Joint Replacement
3. Cardiovascular Systems Announces Plans for Second Manufacturing Facility - New Facility Expands CSI's Capacity to Produce Peripheral Arterial Disease Systems
4. 8 Ounces a Day of POM Wonderful 100% Pomegranate Juice May Slow Progression of Carotid Intima-Media Thickness (CIMT) in Patients with Elevated Cardiovascular Disease Risk Factors, Study Finds
5. BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease
6. MAQUET Cardiovascular Receives FDA Clearance for MEGA(TM), the Worlds First 8Fr. 50cc Intra-Aortic Balloon Catheter
7. Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics (TCT) Meeting
8. Concentric Medical Launches Full Family of DAC(TM) Neurovascular Catheters
9. Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics (TCT) 2009
10. Health Leaders Issue Recommendations to Improve Management of a Common, Costly and Misunderstood Cardiovascular Disease: Atrial Fibrillation
11. Dr. Eliscer Guzman, with The Mount Sinai Medical Center, Join Forces to Celebrate the Community Diabetes and Cardiovascular Care Programs Graduation Ceremony on September 16th
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Vascular Study Group of New England Selects Clinical Data Pathways, Powered by M2S, as Quality Improvement Registry Provider
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: